Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke
Mohammed Almekhlafi(University of Calgary), Tobien H.C.M.L. Schreuder(Hermes Arzneimittel (Germany)), Boudewijn A.A.M. van Hasselt(Hermes Arzneimittel (Germany)), Tudor G. Jovin(Cooper University Hospital), Jan Albert Vos(Hermes Arzneimittel (Germany)), Bart J. Emmer(Amsterdam University Medical Centers), Geert J. Lycklama à Nijeholt(GGD Haaglanden), Paul J. Nederkoorn(Hermes Arzneimittel (Germany)), Willem Jan J. van Rooij(Hermes Arzneimittel (Germany)), Joost Bot(Hermes Arzneimittel (Germany)), Andrew M. Demchuk(University of Calgary), Jeannette Hofmeijer(Rijnstate Hospital), Charles B.L.M. Majoie(Amsterdam University Medical Centers), Leo A.M. Aerden(Hermes Arzneimittel (Germany)), Phil White(Newcastle University), Albert J. Yoo(Los Angeles Medical Center), Hester F. Lingsma(Erasmus MC), Debbie Beumer(Maastricht University), Serge Bracard(Inserm), Keith W. Muir(University of Glasgow), Wouter J. Schonewille(Universität Hamburg), Ewoud J. van Dijk(Hermes Arzneimittel (Germany)), Diederik W.J. Dippel(Erasmus MC), Jelis Boiten(University Medical Center Utrecht), Patrick A. Brouwer(Hermes Arzneimittel (Germany)), René J. Dallinga(Hermes Arzneimittel (Germany)), Olvert A. Berkhemer(Erasmus MC), Marieke J.H. Wermer(Leiden University Medical Center), Julie Staals(Maastricht University), Sebastiaan F. de Bruijn(Hermes Arzneimittel (Germany)), Peter Mitchell(The Royal Melbourne Hospital), L. Jaap Kappelle(University Medical Center Utrecht), Bruce Campbell(The Royal Melbourne Hospital), Jeffrey L. Saver(University of California, Los Angeles), Mayank Goyal(University of Calgary), Paul L.M. de Kort(Hermes Arzneimittel (Germany)), Lukas C. van Dijk(Hermes Arzneimittel (Germany)), Michael D. Hill(University of Calgary), Marieke C. Visser(Hermes Arzneimittel (Germany)), Françis Guillemin(Institute for Work & Health), Lucie A. van den Berg(Academic Medical Center), Jan S.P. van den Berg(Hermes Arzneimittel (Germany)), Jacques A. van Oostayen(Hermes Arzneimittel (Germany)), Patrick C. Vroomen(Hermes Arzneimittel (Germany)), Marianne A. A. van Walderveen(Hermes Arzneimittel (Germany)), Puck Fransen, Scott Brown(Altair Engineering (United States)), Rob H. Lo(Hermes Arzneimittel (Germany)), Joost de Vries(Radboud University Nijmegen), Omid Eshghi(Hermes Arzneimittel (Germany))
Cited by 63
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
|New England Journal of Medicine|2014|6.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k